Competing risk and heterogeneity of treatment effect in clinical trials.
about
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposalInforming evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseasesImplantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials.Clinical Trials in Veterinary Medicine: A New Era Brings New Challenges.The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risksOutcomes and statistical power in adult critical care randomized trialsEffects of personalized colorectal cancer risk information on laypersons' interest in colorectal cancer screening: The importance of individual differences.Caring for patients with kidney disease: shifting the paradigm from evidence-based medicine to patient-centered care.The "number needed to treat" turns 20--and continues to be used and misusedHow to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.Against pragmatism: on efficacy, effectiveness and the real world.Dynamic treatment selection and modification for personalised blood pressure therapy using a Markov decision process model: a cost-effectiveness analysis.A new generation of pragmatic trials of psychosocial interventions is needed.
P2860
Q24288920-0A16AD6A-F32E-4A85-A374-0EB9CC4537CDQ27023214-5EDC937F-F52F-4B70-9C86-1F8F623DECA6Q30755342-ABF80223-C5BB-4B3A-8928-CA4167FCD925Q33900204-A9E11689-E96D-484F-AB0D-FB9091A17332Q34337405-8161E01F-09C1-48CD-9098-E7235EC8AB5CQ34480195-32F7C327-F3C7-4574-B61A-223CCDA981CDQ36068708-96C0B1B5-F88A-4642-B79D-1D0312A71DF1Q36603768-D424319F-E1D2-460F-B9C3-2A72CCB3EA72Q36856802-097BDA86-9CDB-480A-824A-676E0E2226DFQ38068890-D460F831-F976-4C28-8F86-298373F7A055Q41763663-1E497DA9-7C6E-4717-B7F6-B3985F0E592EQ45982769-23181DFE-DA65-42F6-84AC-81EF39C1079BQ50717763-267B2D15-B61E-4B39-8FFE-1084DEE8800B
P2860
Competing risk and heterogeneity of treatment effect in clinical trials.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Competing risk and heterogeneity of treatment effect in clinical trials.
@ast
Competing risk and heterogeneity of treatment effect in clinical trials.
@en
type
label
Competing risk and heterogeneity of treatment effect in clinical trials.
@ast
Competing risk and heterogeneity of treatment effect in clinical trials.
@en
prefLabel
Competing risk and heterogeneity of treatment effect in clinical trials.
@ast
Competing risk and heterogeneity of treatment effect in clinical trials.
@en
P2093
P2860
P356
P1433
P1476
Competing risk and heterogeneity of treatment effect in clinical trials.
@en
P2093
Alawi Alsheikh-Ali
David M Kent
Rodney A Hayward
P2860
P2888
P356
10.1186/1745-6215-9-30
P577
2008-05-22T00:00:00Z
P5875
P6179
1037319251